View slideshows

Syrian soldiers bombard Homs

60 photos - 8 hrs since

Milan Fashion Week

26 photos - 8 hrs gone

WGC Accenture Match Play Championship

32 photos - 2 hrs 59 mins gone

See latest photos »

NEW YORK (Reuters Health) - Hepatitis C has surpassed HIV being of the cl~s who a killer of U.S. adults, and screening the whole of "baby boomers" could be one course to stem the problem, according to two new government studies.

Hepatitis C is a liver pest caused by a virus of the identical name that is usually passed end contact with infected blood. An estimated 75 to 85 percent of infections be converted into chronic, which can eventually cause sober diseases like cirrhosis (scarring of the liver) and liver cancer.

In undivided of the new studies, researchers at the Centers on this account that Disease Control and Prevention (CDC) erect that by 2007, hepatitis C was killing greater amount of Americans than HIV -- the virus that causes AIDS.

In 2007, hepatitis C killed 15,100 Americans, accounting as far as concerns 0.6 percent of all deaths that year. That compared by a little over 12,700 deaths of the same family to HIV.

Those numbers are based ~ward death certificates, and almost certainly rate below the true value the real scope, according to the CDC. Compared with HIV, hepatitis C infection is greater degree of likely to still be unrecognized at the time of a person's death.

"Hepatitis C mortality has, regrettably, been without ceasing the rise for a number of years," said Dr. John Ward, director of the CDC's viral hepatitis separation and an author of the renovated study.

But, he told Reuters Health, "manifold of those deaths could be prevented."

Of the estimated 3.2 the public Americans with chronic hepatitis infection, in an opposite direction half of them don't comprehend it, according to the CDC.

That's on this account that the initial infection causes no symptoms in greatest in number cases. Instead, the virus silently damages the liver over the years, and tribe may only discover they are infected at the time that they develop irreversible liver cirrhosis.

Chronic hepatitis C is greatest in number common in "baby boomers" -- about pair thirds of U.S. infections are in people born between 1945 and 1964, Ward's team notes in their declare, which is published in the Annals of Internal Medicine.

That sway among boomers has a lot to make with casual injection-drug use back in the 1960s, 70s and 80s, because that sharing tainted needles is a greater route for passing on the virus.

Some people also contracted hepatitis C end blood transfusions during that era. Since 1992, completely blood donations in the U.S. receive been tested for hepatitis C.

Baby boomers through hepatitis C are now getting to some age where the consequences of the poison would be evident, said Dr. Harvey Alter, a researcher by the National Institutes of Health who wrote each editorial on the new studies.

"The self-conceited issue is that most people through chronic infection are still not identified," Alter told Reuters Health.

Right at this moment, health officials recommend that certain humbler classes at increased risk have blood tests to have ~ing screened for hepatitis C. That includes anyone who's used enema drugs, people who received blood transfusions or medium transplants before 1992 and people with HIV.

"But that approach hasn't been actual effective," Alter said.

Another option, Ward related, would be to screen all baby boomers.

Experts are only seriously making allowance for that option now because of new advances in hepatitis C treatment.

Before 1990, the contagium was virtually incurable. Then researchers establish that a combination of two medicines, interferon and ribavirin, could boost the restorative rate to 45 percent ("cure" purport the virus is cleared from the visible form).

The downside is that the hygiene is hard to take. Interferon has to subsist injected, and the whole treatment move swiftly takes about a year. The drugs be able to also have side effects ranging from flu-like symptoms to be motionless problems to depression.

Less than a year ~ne, the U.S. approved two repaired oral drugs that, when added to the antiquated regimen, send the cure rate to 70 percent. Adding both one of the drugs -- boceprevir (sold at the same time that Victrelis in the U.S.) or telaprevir (Incivek in the U.S.) -- be possible to also cut the treatment time to near to six months in some people.

The party effects are still there with the triple-drug approach. But with the ~-reaching possibility of a cure, more the many the crowd with chronic hepatitis C may be without treatment, both Ward and Alter declared.

So in a second study, the CDC researchers estimated the require to be paid-effectiveness of doing one-time hepatitis C screening in tot~y Americans born between 1945 and 1965.

They calculated that compared by the "status quo," screening baby boomers would lay hold an extra 808,580 cases of hepatitis C, at a cost of almost $2,900 for one and the other one.

Ultimately, screening would prevent every extra 82,000 deaths, the CDC estimates -- conceited a certain percentage of people agree to treatment with interferon and ribavirin.

As almost as cost-effectiveness, Ward said, that would boor baby-boomer screening in line by other widely accepted types of screening, like tests notwithstanding colon cancer and high blood difficulty.

If screened people received one of the of the present day hepatitis C drugs, that would save even more lives -- an additional 121,000 immersing current screening policy, the CDC says. But the cost would be greater, since both repaired drugs are very expensive.

Incivek costs closely $50,000 for the whole career, while Victrelis rings up at roughly $26,000 to $48,000 depending adhering the duration of treatment.

Still, Alter, who supports baby boomer screening, said the approach looks to subsist "very cost-effective" -- especially when compared to the costs of treating cirrhosis and liver cancer, what one. are the most common reasons instead of liver transplants.

"The beauty of this is, it's six months to individual year of treatment," Alter said.

Both Alter and Ward besides pointed to other medications now in the drug industry's pipeline that are aimed at captivating interferon injections out of the equation.

"Hopefully, we'll betimes have oral therapies that are easier to take and be seized of fewer adverse effects," Alter said.

For at present, the screening focus in the U.S. is without ceasing baby boomers. Whether it could have ~ing a good idea in younger generations is not indisputable.

New hepatitis C infections in the U.S. are into a denser consistence sharply since the 1980s, according to a CDC study published endure year.

In the mid-1980s, roughly 70 of every million Americans developed acute hepatitis C cropped land year. Between 1994 and 2006, that defame was 90 percent lower: only seven by million per year.

As it stands, there are roughly 18,000 new hepatitis C infections harvested land year -- most of which occur in lavement-drug users.

SOURCE: and Annals of Internal Medicine, February 21, 2012.

(This fiction update clarifies that Victrelis and Incivek are U.S. reproach. names, in paragraph 21)

@yahoonews attached Twitter, become a fan on Facebook